| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2000 European Society of Cardiology
Annual scientific and financial report
Working Group on Heart Failure European Society of Cardiology: September 1999–August 2000
Department of Medicine, Sahlgreska University, Hospital/Ostra Göteberg, Sweden
| The first 10% of the full text of this article appears below. |
The Working Group aims to promote organised research in the field of heart failure. Heart failure is a major and growing health problem in industrialised countries. Estimates of the prevalence of the condition are few, but suggest that between 1 and 4% of the entire population is affected. The incidence and prevalence rise exponentially with age.
Heart failure is attended by a heavy burden of symptoms and a high incidence of complications. Consequently, the impact of heart failure on the national economies is great, not only due to the need for treatment and frequent hospitalisation, but also due to the loss of gainful employment by the patient and/or their carers. Moreover, it has a poor prognosis, with an
| 1. Nucleus |
|---|
| 2. Meetings |
|---|
| 3. Finances |
|---|
| 4. Journal |
|---|
| 5. ESC |
|---|
5.1. The EuroHeart Survey
5.2. Report from the Study Group on Diagnosis
5.3. Science council
5.4. Website
5.5. Task force
| 6. Other societies |
|---|